Alexander S Onassis Public Benefit Foundation

Content and FocusPerson-centred therapy (PCT) and psychodynamic therapy frequently comprise two of the modalities that counselling psychologists are exposed to during their training, while the key concepts drawn from these domains continue to inform the practice of chartered counselling psychologists. Rogers’ ideas came at a time when psychodynamic thinking had established a firm grip over therapeutic orthodoxy and challenged the practice of psychoanalysis, even as they circumvented its theoretical underpinnings. This paper explores the extent to which the six necessary and sufficient, or core, conditions of therapeutic change can manifest in a psychodynamic therapy encounter. The author reviews relevant literature that juxtaposes PCT and psychodynamic understandings of therapeutic theory and practice whilst examining each of the conditions sequentially in the light of some key psychodynamic concepts.ConclusionsThe question posed by this paper requires an idiosyncratic answer that can be neither authoritatively nor objectively obtained. It is argued that our discipline’s epistemological position might facilitate a diffusion of the core conditions into the implicit theoretical apparatus that Sandler (1983) has identified as guiding the practice of psychoanalysts. I reflect on my personal journey of grappling with this issue before tentatively arriving at the conclusion that the conditions can indeed be present in psychodynamic practice, even if noticeably absent from psychodynamic theory.

Evaluate the performance and safety of the FiberNet Embolic Protection System during carotid artery intervention. Carotid Angioplasty and Stenting (CAS) can be proposed to treat the majority of carotid stenoses. Brain embolization takes place and routine use of Embolic Protection Devices (EPD) is warranted. Many EPDs have significant limitations, which may be addressed by a new EPD, the FiberNet (Lumen Biomedical, Plymouth, MN). The system consists of a 3-dimensional expandable filter made of fibers, which expand radially, mounted onto a 0.014'' wire and retrieval catheter. FiberNet can capture particles as small as 40 microm without compromising flow. 35 lesions treated in 34 patients. Male 67.6%. Age: 71.4 +/- 8.8 (50-85). Average stenosis 84.5% +/- 7.9 (70-99). 29.4% were symptomatic. Technical success: 34/35 (97%). No stroke or death within 30 days. Neurological events: two permanent amaurosis, one amaurosis fugax. All samples visually contained significant amounts of emboli. The mean surface area of debris caught was 63.8 mm(2) (37.7-107.5). Comparisons were made with other EPDs. The mean surface area of debris caught was 12.2 mm(2) (2.7-34.3). No changes were noted in CT/MRI at 30-day post procedure. The first human use of this new novel EPD in carotid artery stenting is encouraging. The FiberNet was easy to use and confirmed the ability to capture particles less than 100 microm. The feasibility of the FiberNet has been demonstrated. Additional patients will demonstrate the overall safety and efficacy of this new EPD device.